MRK
Price
$84.01
Change
-$0.17 (-0.20%)
Updated
Sep 4, 04:59 PM (EDT)
Capitalization
210.26B
56 days until earnings call
NVO
Price
$56.31
Change
-$0.43 (-0.76%)
Updated
Sep 4, 02:27 PM (EDT)
Capitalization
252.56B
62 days until earnings call
Interact to see
Advertisement

MRK vs NVO

Header iconMRK vs NVO Comparison
Open Charts MRK vs NVOBanner chart's image
Merck & Co
Price$84.01
Change-$0.17 (-0.20%)
Volume$165.42K
Capitalization210.26B
Novo-Nordisk A/S
Price$56.31
Change-$0.43 (-0.76%)
Volume$878
Capitalization252.56B
MRK vs NVO Comparison Chart in %
Loading...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRK vs. NVO commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRK is a Hold and NVO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (MRK: $84.18 vs. NVO: $56.74)
Brand notoriety: MRK: Notable vs. NVO: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: MRK: 113% vs. NVO: 51%
Market capitalization -- MRK: $210.26B vs. NVO: $252.56B
MRK [@Pharmaceuticals: Major] is valued at $210.26B. NVO’s [@Pharmaceuticals: Major] market capitalization is $252.56B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $661.43B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $90.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRK’s FA Score shows that 2 FA rating(s) are green whileNVO’s FA Score has 2 green FA rating(s).

  • MRK’s FA Score: 2 green, 3 red.
  • NVO’s FA Score: 2 green, 3 red.
According to our system of comparison, both MRK and NVO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRK’s TA Score shows that 5 TA indicator(s) are bullish while NVO’s TA Score has 4 bullish TA indicator(s).

  • MRK’s TA Score: 5 bullish, 4 bearish.
  • NVO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NVO is a better buy in the short-term than MRK.

Price Growth

MRK (@Pharmaceuticals: Major) experienced а +0.13% price change this week, while NVO (@Pharmaceuticals: Major) price change was +0.53% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.37%. For the same industry, the average monthly price growth was +1.83%, and the average quarterly price growth was +9.29%.

Reported Earning Dates

MRK is expected to report earnings on Oct 30, 2025.

NVO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.37% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVO($253B) has a higher market cap than MRK($210B). NVO has higher P/E ratio than MRK: NVO (14.49) vs MRK (12.97). MRK YTD gains are higher at: -13.794 vs. NVO (-32.220).
MRKNVOMRK / NVO
Capitalization210B253B83%
EBITDA25BN/A-
Gain YTD-13.794-32.22043%
P/E Ratio12.9714.4990%
Revenue63.6BN/A-
Total Cash8.62BN/A-
Total Debt35.4BN/A-
FUNDAMENTALS RATINGS
MRK vs NVO: Fundamental Ratings
MRK
NVO
OUTLOOK RATING
1..100
7518
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
7477
SMR RATING
1..100
2715
PRICE GROWTH RATING
1..100
5664
P/E GROWTH RATING
1..100
9198
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRK's Valuation (9) in the Pharmaceuticals Major industry is in the same range as NVO (16). This means that MRK’s stock grew similarly to NVO’s over the last 12 months.

MRK's Profit vs Risk Rating (74) in the Pharmaceuticals Major industry is in the same range as NVO (77). This means that MRK’s stock grew similarly to NVO’s over the last 12 months.

NVO's SMR Rating (15) in the Pharmaceuticals Major industry is in the same range as MRK (27). This means that NVO’s stock grew similarly to MRK’s over the last 12 months.

MRK's Price Growth Rating (56) in the Pharmaceuticals Major industry is in the same range as NVO (64). This means that MRK’s stock grew similarly to NVO’s over the last 12 months.

MRK's P/E Growth Rating (91) in the Pharmaceuticals Major industry is in the same range as NVO (98). This means that MRK’s stock grew similarly to NVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRKNVO
RSI
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
47%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 3 days ago
47%
Bullish Trend 14 days ago
67%
Declines
ODDS (%)
Bearish Trend 8 days ago
52%
Bearish Trend 10 days ago
59%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
43%
Aroon
ODDS (%)
Bullish Trend 2 days ago
58%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IHRT2.310.07
+3.12%
iHeartMedia
NBHC39.030.02
+0.05%
NATIONAL BANK HOLDINGS Corp
R186.05-0.82
-0.44%
Ryder System
SLNHP2.45-0.07
-2.78%
Soluna Holdings
SCWO0.33-0.01
-3.98%
374Water

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with PFE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-1.52%
PFE - MRK
58%
Loosely correlated
-0.76%
BMY - MRK
50%
Loosely correlated
+0.19%
BIIB - MRK
50%
Loosely correlated
+1.43%
NVS - MRK
48%
Loosely correlated
+1.26%
AZN - MRK
46%
Loosely correlated
+2.39%
More

NVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been loosely correlated with ADAP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NVO jumps, then ADAP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
+0.64%
ADAP - NVO
38%
Loosely correlated
-9.00%
GMAB - NVO
35%
Loosely correlated
+4.60%
TECH - NVO
35%
Loosely correlated
-0.15%
BCAB - NVO
35%
Loosely correlated
+9.06%
MRK - NVO
34%
Loosely correlated
-1.52%
More